Company / Debt per Share
Phathom Pharmaceuticals, Inc. Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$3.05
FY2025
5-year range
$2.42 / $3.47
FY2021-FY2025
Trend
-12.2%
vs FY2024
Sector context
#33 of 82
Health Care
What the data says
At $3.05, Phathom Pharmaceuticals, Inc.'s debt per share ranks #50 of 82 in the Health Care sector. Improved from $3.32 to $3.05 over the past 2 years.
Based on SEC 10-K filings.
3.05 in FY2025 with a 5-year CAGR of +20.7%.
Improved from $3.32 to $3.05 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- +20.7%
- 10-Year CAGR
- -
Sector benchmark
#50 of 82 in Health CareTop 60% of 82This company $3.05 Sector average $126.59
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 12.2% year-over-year.
- Ranks #33 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2024.
- Lowest debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.05 | -12.2% |
| FY2024 | $3.47 | +4.5% |
| FY2023 | $3.32 | +36.5% |
| FY2022 | $2.44 | +0.5% |
| FY2021 | $2.42 | +103.2% |
| FY2020 | $1.19 | -40.5% |
| FY2019 | $2.00 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026